Clinical Trials on Relapsed Large Cell Lymphoma
Total 9019 results
-
Asan Medical CenterEnrolling by invitation
-
Asan Medical CenterEnrolling by invitation
-
Xinjiang Medical UniversityUnknownDiffuse, Large B-Cell, LymphomaChina
-
Mansoura UniversityUnknown
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Hebei Medical University Fourth HospitalUnknownDiffuse Large B-cell LymphomaChina
-
University Hospital, CaenUnknownDiffuse Large B Cell Lymphoma
-
National Cancer Centre, SingaporeGlaxoSmithKlineCompletedDiffuse Large B-cell LymphomaSingapore
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Korea University; Yonsei University and other collaboratorsCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
Fudan UniversityTerminated
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
Fudan UniversityUnknown
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Chulalongkorn UniversityBayerTerminatedDiffuse Large B-cell LymphomaThailand
-
Adaptive BiotechnologiesStanford UniversityRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
University of Alabama at BirminghamNot yet recruitingLymphoma, Follicular | Lymphoma, B-Cell | Diffuse Large B Cell LymphomaUnited States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
The Lymphoma Academic Research OrganisationPfizer; Takeda; Hôpital Necker-Enfants Malades; Fondation ARCCompletedAnaplastic Large Cell Lymphoma, ALK-PositiveFrance
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
M.D. Anderson Cancer CenterCompletedLymphoma | Diffuse Large Cell LymphomaUnited States
-
Eli Lilly and CompanyCompletedLymphoma, Large Cell, DiffuseFrance, Germany, Russian Federation
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma | AIDS-related Lymphoma | Adult Non-Hodgkin's Lymphoma
-
Columbia UniversityCompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaCanada, United States
-
Xencor, Inc.CompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCD30-Positive Diffuse Large B-Cell Lymphoma | CD30 Positive Primary Mediastinal Large B-cell Lymphoma | CD30-Positive Gray Zone LymphomaUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphomaBelgium, Spain, Czechia, Hungary, Croatia, Portugal, Turkey, Poland, United Kingdom, Romania
-
University of Milano BicoccaCompletedAnaplastic Large Cell Lymphoma, ALK-PositiveItaly
-
Mingzhi ZhangUnknownALK-Positive Anaplastic Large Cell LymphomaChina
-
David Rizzieri, MDNovartis PharmaceuticalsTerminatedLymphoma, Large-Cell, DiffuseUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
Sohag UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingLymphoma, Non-Hodgkin | Diffuse Large B Cell LymphomaChina
-
Centre Henri BecquerelNot yet recruitingDiffuse Large B Cell LymphomaFrance
-
The First Hospital of Jilin UniversityCSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRecruitingDiffuse Large B Cell LymphomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.RecruitingDiffuse Large B-cell LymphomaUnited States
-
First Affiliated Hospital of Wenzhou Medical UniversityRecruitingDiffuse Large B Cell LymphomaChina
-
University of SouthamptonMerck Sharp & Dohme LLCRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Diffuse Large B Cell LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Korea, Republic of, United Kingdom, France, Poland, Australia, Belgium, China, Spain, Taiwan, Switzerland, Germany, Denmark, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore